BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 16, 2012
View Archived Issues
New resource makes genome data and interpretations public
Read More
Chinese researchers present novel inhibitors of platelet aggregation
Read More
Nerviano Medical Sciences discloses new protein kinase inhibitors
Read More
Novartis patents new CDK9/cyclin-T1 inhibitors
Read More
Novel B-raf inhibitors divulged by Boehringer Ingelheim
Read More
Novel RAR-related orphan receptor-gamma modulators developed
Read More
Novel candidate HIV drugs designed by GlaxoSmithKline
Read More
Curegenix reports new lysophospholipid LPA1 receptor antagonists
Read More
New candidate analgesics synthesized at Eli Lilly
Read More
Model allows prediction of bacterial responses to multidrug combinations
Read More
New potential stroke therapeutic enters clinic
Read More
Ark Therapeutics and EMD Millipore take first collaborative steps for virus vaccines
Read More
ReNeuron clear to advance phase I stem cell trial
Read More
European study reveals new marker of stroke outcome
Read More
Treatment begins in phase I trial of SOR-C13
Read More
Biovest holds end-of-phase III meeting for BiovaxID
Read More
FDA advisory committee schedules review of lomitapide NDA
Read More
Aptalis launches new pancrelipase tablets in U.S.
Read More
Fusion protein blocking BMP signaling stimulates bone formation
Read More
HSV-2 vaccine enters phase I/IIa study
Read More
Sublingual fibromyalgia medication shows promise for chronic use
Read More
GMP development of CS-TATI-1 begins
Read More
Mologen announces progress in first half of 2012
Read More
FDA accepts complete response regarding Ampligen NDA
Read More
Natural immunomodulator for Crohn's disease enters new trial
Read More
Debio-0932 enters new NSCLC study
Read More